Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen, Netta
Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. [electronic resource] - Molecular cancer 06 2017 - 101 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-4598
10.1186/s12943-017-0672-1 doi
Biomarkers, Tumor
DNA Mutational Analysis
Female
Fumarate Hydratase--genetics
Gene Expression
HMGA2 Protein--genetics
Humans
Mediator Complex--genetics
Mutation
Neoplasm Grading
Retrospective Studies
Smooth Muscle Tumor--genetics
Uterine Neoplasms--genetics
Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. [electronic resource] - Molecular cancer 06 2017 - 101 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-4598
10.1186/s12943-017-0672-1 doi
Biomarkers, Tumor
DNA Mutational Analysis
Female
Fumarate Hydratase--genetics
Gene Expression
HMGA2 Protein--genetics
Humans
Mediator Complex--genetics
Mutation
Neoplasm Grading
Retrospective Studies
Smooth Muscle Tumor--genetics
Uterine Neoplasms--genetics